
Bradford Hoppe
@hoppebrad
One-wheeler, lympho-maniac, Particle therapy guru, rad onc researcher, husband, dad x3 boys. Livin’ the beach/salt life. tweets=mine
ID: 870667042243981312
02-06-2017 15:42:53
298 Tweet
682 Followers
226 Following

Florida Rad Onc representing #ACR2024 CARROS Mayo Clinic Radiation Oncology Laura Vallow, MD and Jennifer Peterson



Exciting work by Star resident Brady Laughlin, soon to be Mayo Faculty. Great mentorship by William Rule. @TheColonelGray William Breen Fine-Tuning Low-Dose Total Skin Electron Therapy for Optimal Management of Cutaneous T-Cell Lymphoma advancesradonc.org/article/S2452-…

Excited to finally open Poseidon Trial after 2 years of hard work with resident Omran Saifi, MD . RCT 9Gy (3x3) vs 24Gy in indolent lymphoma. First patient enrolled and randomized last week. Mayo Clinic Florida Radiation Oncology Residency Mayo Clinic Comprehensive Cancer Center William Breen @TheColonelGray clinicaltrials.gov/study/NCT06386…


We highlight Journal of Clinical Oncology the importance of addressing RT tox that matters most to pts when comparing proton to IMRT for prostate ca. Protons can⬇️ low dose bath➡️reduce bowel freq/urg—two most bothersome tox for pts. Bradford Hoppe Albert Attia Mayo Clinic Comprehensive Cancer Center doi.org/10.1200/jco.24…


Omran Saifi, MD receiving ASTRO #ROI presents publication award for his work on CAR T cell therapy and RT for NHL Mayo Clinic Comprehensive Cancer Center Mayo Clinic Florida Radiation Oncology Residency I’m a proud mentor.


Sarah Milgrom, MD great job presenting Children’s Oncology Group 0431 transplant-free salvage for low risk Hodgkin lymphoma. David Hodgson Kara Kelly Sharon M. Castellino


The National Cancer Institute NRG Oncology Children’s Oncology Group SWOG Cancer Research Network ECOG-ACRIN Cancer Research Group Alliance for Clinical Trials in Oncology CCTG consensus nomenclature for contemporary lymphoma radiation target volumes Bradford Hoppe Chelsea C Pinnix MD PhD Sarah Milgrom, MD Leslie Ballas Nick Figura, MD David Hodgson Rahul R. Parikh, MD, MBA Stephanie Terezakis

Another set of great images from Omran Saifi, MD to show how RT has evolved in management of lymphoma. Thanks Dr Diefenbach for the opportunity to share.

1/3 studies published on transplant-free approach for relapsed Hodgkin that uses RT. Key point in this study-OS not impacted in low risk rHL when HDT/ASCT pushed to 3rd line. Transplant-Free Salvage Therapy for Low-Risk Relapsed Pediatric Hodgkin Lymphoma jamanetwork.com/journals/jamao…


3/3 transplant-free salvage for relapsed HL Children’s Oncology Group + Euronet + BMS prospective phase 2 study using novel therapies + ISRT with excellent 3 yr PFS Transplant-Free Approach in Relapsed Hodgkin Lymphoma in Children, Adolescents, and Young Adults jamanetwork.com/journals/jamao…


Our NRG Oncology HemeGroup #RadiateEquity initiative The Lancet Haematology ➡️RadOncs are underrepresented in lymphoma NCCN committees, cooperative groups, research foundations and heme journals editorial boards Multi-D improves pts outcomes! Bradford Hoppe Chelsea C Pinnix MD PhD doi.org/10.1016/S2352-…

Radiate equity: the inclusion of radiation oncology and other specialt... sciencedirect.com/science/articl… RT still has an important role in lymphoma, especially using smaller fields & cutting edge tech. Let’s make sure Rad Oncs have a seat at the table. NRG Oncology ILROG Team


Excited to help bring CIRT back to the U.S. Still a long road ahead, but proud to be part of the journey. Mayo Clinic Comprehensive Cancer Center Mayo Clinic Radiation Oncology Laura Vallow, MD

High risk pediatric HL study exploratory analysis showed similar PFS with protons, but much lower dose to heart, lungs, breast. By end of study, 1/3 of pts were receiving protons. Comparison of Contemporary Radiation Therapy Approaches in Combined Mo... sciencedirect.com/science/articl…